Monday, September 28, 2015 4:14:20 PM
yes ugly but will certainly take it.IMO sellers are gone accumulation between .36 .42 then next leg
My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.
Recent PHIO News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 11:15:34 AM
- Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762 • Newsfile • 03/30/2026 11:00:00 AM
- Phio Pharmaceuticals Announces American Academy of Dermatology 2026 Presentation Featuring Clinical Study Results from Study of PH-762 for Cutaneous Carcinoma Underscoring Clinical Pipeline Advancement • Newsfile • 03/23/2026 11:00:00 AM
- Phio Pharmaceuticals Announces "A Groundbreaking Approach to Treating Skin Cancer" in a Fireside Chat with Force Family Office • Newsfile • 03/16/2026 03:30:00 PM
- Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 03/13/2026 12:35:00 PM
- Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th • GlobeNewswire Inc. • 03/10/2026 02:21:44 PM
- Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026 11 AM EDT • GlobeNewswire Inc. • 03/10/2026 12:35:00 PM
- Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026 11 AM EDT • GlobeNewswire Inc. • 03/10/2026 11:59:39 AM
- Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026, 11 AM EDT • Newsfile • 03/10/2026 11:00:00 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/05/2026 09:17:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 09:10:23 PM
- Phio Pharmaceuticals Reports 2025 Year-End Financial Results and Business Update • Newsfile • 03/05/2026 09:05:00 PM
- Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series • Newsfile • 03/05/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 09:01:20 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 07:49:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/10/2026 12:33:55 PM
- Phio Announces Safety Monitoring Committee's (SMC) Positive Wrap-up on Lead Clinical Candidate PH-762 in Skin Cancer Trial • Newsfile • 02/10/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2026 01:00:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2026 12:59:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2026 12:58:27 PM
- Phio Pharmaceuticals Announces Participation in Third Annual DealFlow Discovery Conference • Newsfile • 01/26/2026 01:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/20/2026 02:33:00 PM
- Phio Pharmaceuticals Announces Key Tumor Response Data from all Cohorts in Intratumoral PH-762 Dose Escalation Cutaneous Carcinoma Trial • Newsfile • 01/20/2026 02:30:00 PM
- Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference January 21-22, 2026 • Newsfile • 01/15/2026 01:45:00 PM
